Companies: 10,795·Total market cap: $144.5T
Innovent Biologics, Inc.

Innovent Biologics, Inc.

IVBXFOTCHealthcare● Active
$9.10
$-0.99(-9.85%)
Market Cap$15.8B
P/E Ratio—
52W High$15.12
52W Low$9.01
Overview
股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Innovent Biologics, Inc.（IVBXF）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · IVBXF · 截至 Jun 8, 2026

关键指标

EPS (TTM)$0.43ivbxf eps ttm · ivbxf earnings per shareEarnings history
PE Ratio (TTM)21.3×ivbxf pe ratio ttm · ivbxf price to earningsPE Ratio deep dive
Revenue (TTM)$22.3Bivbxf revenue ttm · ivbxf annual revenueFull revenue history
Dividend Yield不分红does ivbxf pay dividends · ivbxf dividend yieldDividend history
Shares Outstanding1.68Bivbxf shares outstanding · ivbxf floatShares outstanding history
Next EarningsAug 26, 2026Est.ivbxf earnings date · ivbxf next earningsEarnings history

探索 Innovent Biologics, Inc. 数据

ivbxf stock data · financials
市值$15.8Bivbxf market cap · ivbxf valuation
分析师预测—
股息不分红does innovent biologics, inc. pay dividends · ivbxf dividend yield
营收$12.7B+34.85%innovent biologics, inc. annual revenue · ivbxf revenue
盈利EPS $0.47+908.95%ivbxf earnings · ivbxf eps
市盈率21.3×ivbxf pe ratio · ivbxf price to earnings

财务快照

完整财报
FY 2025Revenue$12.70B▲ +34.85% YoY
202320242025
innovent biologics, inc. revenue · ivbxf revenue 2025
FY 2025Net Income$792.6M▲ +937.54% YoY
202320242025
innovent biologics, inc. net income · ivbxf profit 2025
FY 2025EPS$0.47▲ +908.95% YoY
202320242025
ivbxf eps · innovent biologics, inc. earnings per share 2025
TTM:Revenue: $22.35BNet Income: $719.3MEPS: $0.43View income statement →

股票表现

完整历史
1D-9.85%
1W-11.13%
1M-11.65%
3M-8.54%
YTD-6.67%
1Y-9.72%
5Y-18.75%

关于 Innovent Biologics, Inc.

CEODe-Chao Yu
IPO DateSep 4, 2019
Employees5,659
CountryCN
Websiteinnoventbio.com

Innovent Biologics, Inc. is a biopharmaceutical firm headquartered in Suzhou, People's Republic of China, established in 2011. It specializes in the discovery, advancement, and production of antibody-…

BiotechnologyHealthcareOTCCN

what is innovent biologics, inc. · ivbxf stock overview · innovent biologics, inc. company profile · who is innovent biologics, inc. ceo · ivbxf OTC · innovent biologics, inc. headquarters · innovent biologics, inc. business segments

关于股票概览与关键数据

Innovent Biologics, Inc.（IVBXF）是 Biotechnology 行业的 Healthcare 类公司，于 Sep 4, 2019 在 OTC 上市。截至最近交易日，IVBXF 股价为 $9.10，市值约为 $15.8B。过去12个月累计回报 -9.72%，年初至今回报 -6.67%。

2025 财年 Innovent Biologics, Inc. 营收 $12.7B。完整财务数据（营收历史、盈利、资产负债表）请使用上方标签页。

常见问题

截至最近一个交易日，Innovent Biologics, Inc.（IVBXF）股价为 $9.10，在 OTC 上市，52周区间为 $9.01 – $15.12。

IVBXF 最新股价IVBXF quote todaylive ticker 实时行情
数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议